Login

Investor Drops $30 Million for Industrial Site To Extend Flurry of Deals in Bay Area Biotech Hotbed

Breed's Hill Capital Closes Deal for Site Surrounded By Life Sciences Proposals in South San Francisco
An affiliate of Breed's Hill Capital has acquired the industrial site at 573 Forbes Blvd. for $30 million. (CoStar)
An affiliate of Breed's Hill Capital has acquired the industrial site at 573 Forbes Blvd. for $30 million. (CoStar)
CoStar News
May 18, 2022 | 8:13 P.M.

A Boston Investor is adding more fuel to the San Francisco Bay Area's biotech fire after closing a $30 million deal to acquire a site in the nation's second-largest life science hub.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE